✦ LIBER ✦

Heterogeneity in malignant gliomas: a magnetic resonance analysis of spatial distribution of metabolite changes and regional blood volume

✍ Scribed by Marlies Wagner; Reinhold Nafe; Alina Jurcoane; Ulrich Pilatus; Kea Franz; Johannes Rieger; Joachim P. Steinbach; Elke Hattingen

Book ID: 106481810
Publisher: Springer US
Year: 2010
Tongue: English
Weight: 523 KB
Volume: 103
Category: Article
ISSN: 0167-594X
DOI: 10.1007/s11060-010-0443-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Spatial distribution of mitosis, apoptos

Spatial distribution of mitosis, apoptosis and small blood vessels in malignant diffuse follicular-center-cell lymphomas: A nearest-neighbor analysis

✍ Rainer Kraft; Paolo Barbini; Lorenzo Leoncini; Maria T. Del Vecchio; Tiziana Meg 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 French ⚖ 757 KB

To better comprehend the relationships between cell birth and cell death in neoplastic disorders, the topography of these events needs to be considered. We applied a computerized nearest-neighbor analysis to malignant, diffuse follicular-centercell lymphomas in order to examine the spatial distribut

Regional brain activation by bicuculline

Regional brain activation by bicuculline visualized by functional magnetic resonance imaging. Time-resolved assessment of bicuculline-induced changes in local cerebral blood volume using an intravascular contrast agent

✍ Torsten Reese; Börje Bjelke; Robert Porszasz; Diana Baumann; Damien Bochelen; An 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 511 KB

Functional magnetic resonance imaging (fMRI) has been applied to study rat focal brain activation induced by intravenous administration of the GABA(A) antagonist bicuculline. Using magnetite nanoparticles as a blood pool contrast agent, local changes in cerebral blood volume (CBV) were assessed with

Changes in Tumor Blood Flow as Measured

Changes in Tumor Blood Flow as Measured by Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) May Predict Activity of Single Agent Bevacizumab in Recurrent Epithelial Ovarian (EOC) and Primary Peritoneal Cancer (PPC) Patients: An exploratory analysis of a Gynecologic Oncology Group Phase II study

✍ Dana M. Chase; Michael W. Sill; Bradley J. Monk; Mark D. Chambers; Kathleen M. D 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 842 KB